State Street’s Journey Medical DERM Stock Holding History

State Street’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$467K	Sell	65,978 -171,310	-72%	-$978K	﹤0.01%	3610
2026 Q1	$1.11M	Buy	237,288 +63,951	+37%	+$496K	﹤0.01%	3464
2025 Q4	$1.34M	Buy	173,337 +27,300	+19%	+$214K	﹤0.01%	3460
2025 Q3	$1.04M	Buy	146,037 +31,061	+27%	+$225K	﹤0.01%	3504
2025 Q2	$826K	Buy	114,976 +86,023	+297%	+$595K	﹤0.01%	3527
2025 Q1	$171K	Hold	28,953	–	–	﹤0.01%	3864
2024 Q4	$113K	Buy	28,953 +3,400	+13%	+$18.6K	﹤0.01%	3964
2024 Q3	$144K	Hold	25,553	–	–	﹤0.01%	3897
2024 Q2	$144K	Hold	25,553	–	–	﹤0.01%	3911
2024 Q1	$94K	Hold	25,553	–	–	﹤0.01%	4038
2023 Q4	$147K	Buy	25,553 +13,700	+116%	+$61K	﹤0.01%	3959
2023 Q3	$32.5K	Buy	+11,853	New	+$26.5K	﹤0.01%	4368

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

State Street's DERM Position: Q2 2026 in Review

State Street reduced its Journey Medical (DERM) stake by 72% in Q2 2026, selling an estimated $978K and leaving 65,978 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #3610.

State Street first reported a position in DERM in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.34M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

State Street held 65,978 shares of Journey Medical worth $467K as of Q2 2026.
State Street sold 171,310 Journey Medical shares in Q2 2026, an estimated $978K.
Journey Medical made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3610 holding.
State Street first reported a position in Journey Medical in Q3 2023 and has held it in 12 quarters since.
State Street's Journey Medical position peaked at $1.34M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.